Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.

ABSTRACT:

Introduction

Moyamoya disease (MMD) is an uncommon cause of stroke. Antiplatelet treatment is commonly prescribed for patients with MMD despite the lack of strong evidence supporting its efficacy. We conducted a systematic review to evaluate evidence of antiplatelet treatment and clinical outcomes among patients with MMD.

Methods

A systematic literature search was performed to identify studies that evaluated the association between antiplatelet treatment and clinical outcomes, including ischemic stroke, hemorrhagic stroke, functional outcome, survival, and bypass patency, in patients with MMD. The following databases were searched: PubMed, Embase, Scopus, and the Cochrane Library, from the inception date to February 2022.

Results

Eight studies were included in this sy

SUBMITTER: Kijpaisalratana N 

PROVIDER: S-EPMC11250630 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature